Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 108 articles: HTML format

Single Articles

September 2025
1. RAMASAMY A, Sivananthan A, Mohammed A, Kumaran S M T, et al
   Implications of imaging modalities on coronary vessel reconstruction and computation of the local hemodynamic forces.
   Atherosclerosis. 2025;408:120423.
   PubMed     Abstract available
   
   
   
2. CEDERSTROM S, Wang Y, Lundman P, Alfredsson J, et al
   Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals - an observational cross-sectional study.
   Atherosclerosis. 2025;408:120457.
   PubMed     Abstract available
   
   
   August 2025
3. CANDREVA A, Morbiducci U, Erriquez A, Rizzini ML, et al
   Enhanced coronary physiology assessment with endothelial shear stress predicts residual cardiovascular risk in older patients with myocardial infarction.
   Atherosclerosis. 2025;409:120476.
   PubMed     Abstract available
   
   
   
4. MUENDLEIN A, Leiherer A, Brandtner EM, Geiger K, et al
   Serum leucine-rich alpha-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.
   Atherosclerosis. 2025;407:120413.
   PubMed     Abstract available
   
   
   
5. ALDUJELI A, Tsai TY, Haq A, Puipaite K, et al
   Impact of severe COVID-19 infection on coronary microvascular dysfunction in ANOCA patients: A cross-sectional study.
   Atherosclerosis. 2025;407:120389.
   PubMed     Abstract available
   
   
   July 2025
6. TOFT-NIELSEN F, Emanuelsson F, Nordestgaard BG, Benn M, et al
   Clinical familial hypercholesterolemia, heart healthy dietary adherence, and cardiovascular risk.
   Atherosclerosis. 2025 Jul 24:120463. doi: 10.1016/j.atherosclerosis.2025.120463.
   PubMed     Abstract available
   
   
   
7. GALIMBERTI F, Olmastroni E, Casula M, Xie S, et al
   Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk.
   Atherosclerosis. 2025;408:120451.
   PubMed     Abstract available
   
   
   
8. RIVERO-SANTANA B, Saldana-Garcia J, Jurado-Roman A, Cantolla-Pablo P, et al
   Early anti-inflammatory therapy in acute myocardial infarction: A network meta-analysis of timing-dependent effects in 23 randomized trials and 28,220 patients.
   Atherosclerosis. 2025;408:120443.
   PubMed     Abstract available
   
   
   
9. WHITE JB, Lin A, Montarello NJ, Bursill CA, et al
   Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction.
   Atherosclerosis. 2025;408:120421.
   PubMed     Abstract available
   
   
   
10. TADA H, Furukawa A, Kojima N, Usui S, et al
    Protein-truncating variants of the cholesteryl ester transfer protein gene and risk for coronary artery disease among patients with heterozygous familial hypercholesterolemia.
    Atherosclerosis. 2025;408:120417.
    PubMed     Abstract available
    
    
    June 2025
11. FROBERT O, Pedersen IB, Hjelholt AJ, Erikstrup C, et al
    The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease.
    Atherosclerosis. 2025 Jun 13:120405. doi: 10.1016/j.atherosclerosis.2025.120405.
    PubMed     Abstract available
    
    
    
12. MAGNONI M, Andreini D, Andreotti F, Latini R, et al
    Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques.
    Atherosclerosis. 2025;407:120410.
    PubMed     Abstract available
    
    
    
13. MYLONAS N, Nikolaou PE, Siokatas G, Kostopoulos IV, et al
    Empagliflozin restores cardiac metabolism and suppresses immune activation in acute myocardial infarction.
    Atherosclerosis. 2025;407:120404.
    PubMed     Abstract available
    
    
    
14. WU JY, Chang HY, Kao CL, Hung KC, et al
    Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study.
    Atherosclerosis. 2025;407:120390.
    PubMed     Abstract available
    
    
    
15. FUJIMOTO D, Kinoshita D, Suzuki K, Niida T, et al
    Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina.
    Atherosclerosis. 2025;405:119237.
    PubMed     Abstract available
    
    
    May 2025
16. ELIAS-LOPEZ D, Kobylecki CJ, Vedel-Krogh S, Doi T, et al
    Association of low-grade inflammation and elevated remnant cholesterol with risk of ASCVD and mortality in impaired renal function.
    Atherosclerosis. 2025;406:119241.
    PubMed     Abstract available
    
    
    
17. SUZUKI T, Haberlen S, Peterson TE, Palella F, et al
    Coronary artery calcium and all-cause mortality in the Multicenter AIDS Cohort Study.
    Atherosclerosis. 2025;404:119181.
    PubMed     Abstract available
    
    
    
18. CONTE E, Lee SE, Chang HJ, Hadamitzky M, et al
    Sex related coronary plaque progression patterns among patients with family history as the sole cardiovascular risk factor: A PARADIGM sub-study.
    Atherosclerosis. 2025;404:119184.
    PubMed     Abstract available
    
    
    April 2025
19. SANTOS RD, Ray KK, De Bacquer D, Jennings C, et al
    Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE.
    Atherosclerosis. 2025;405:119215.
    PubMed     Abstract available
    
    
    
20. TADA H, Nohara A, Usui S, Sakata K, et al
    Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.
    Atherosclerosis. 2025;404:119185.
    PubMed     Abstract available
    
    
    
21. FAROOQ S, Generoso G, Bensenor IM, Santos RD, et al
    Low-density lipoprotein-cholesterol subfractions as predictors for coronary artery calcium incidence and progression - The Brazilian longitudinal study of Adult Health (ELSA - Brasil).
    Atherosclerosis. 2025;403:119171.
    PubMed     Abstract available
    
    
    
22. PIVORIUNAS J, Engebretsen I, Vethe NT, Kristiansen O, et al
    Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry data.
    Atherosclerosis. 2025;403:119138.
    PubMed     Abstract available
    
    
    
23. YUAN X, Zhang L, Li X, Chen K, et al
    Differential lipid impact on mortality in patients undergoing CABG versus PCI.
    Atherosclerosis. 2025;403:119141.
    PubMed     Abstract available
    
    
    
24. FUJINO M, Di Giovanni G, Butters Bhsc J, Kataoka Y, et al
    Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS.
    Atherosclerosis. 2025;403:119145.
    PubMed     Abstract available
    
    
    
25. ZHANG P, Wang W, Xu Q, Cui J, et al
    Genetic association of circulating lipids and lipid-lowering drug targets with vascular calcification.
    Atherosclerosis. 2025;403:119136.
    PubMed     Abstract available
    
    
    March 2025
26. RIKHI R, Haidar A, Bhatia HS, Beam K, et al
    Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2025;404:119179.
    PubMed     Abstract available
    
    
    
27. SADLER M, Cannata A, Mackie S, Mondi Anandhakrishna R, et al
    Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction.
    Atherosclerosis. 2025;403:119169.
    PubMed     Abstract available
    
    
    
28. MOK Y, Ballew SH, Schrack JA, Howard CM, et al
    Mid-life physical activity and calcification of coronary arteries, aorta, and cardiac valves in late life: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2025;402:119115.
    PubMed     Abstract available
    
    
    
29. YABUMOTO N, Fujino M, Sugane H, Hosoda H, et al
    Clinical implications of calcification severity adjacent to calcified nodule: Its association with first and recurrent risks of target lesion revascularization after percutaneous coronary intervention.
    Atherosclerosis. 2025;402:119116.
    PubMed     Abstract available
    
    
    
30. ZHENG N, Liu Z, Ding Y, Wang X, et al
    Incremental prognostic value of pericoronary adipose tissue attenuation beyond conventional features in patients with nonobstructive coronary artery disease.
    Atherosclerosis. 2025;402:119075.
    PubMed     Abstract available
    
    
    February 2025
31. ZHANG Y, Wu J, Wang N, Zhu J, et al
    Global burden and national health inequity of ischemic heart disease attributed to kidney dysfunction from 1990 to 2021: Findings from the global burden of disease study 2021.
    Atherosclerosis. 2025 Feb 26:119140. doi: 10.1016/j.atherosclerosis.2025.119140.
    PubMed     Abstract available
    
    
    
32. KRUGER A, Willems van Dijk K, van Heemst D, Noordam R, et al
    Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants.
    Atherosclerosis. 2025;403:119135.
    PubMed     Abstract available
    
    
    
33. CHIGNON A, Lettre G
    Using omics data and genome editing methods to decipher GWAS loci associated with coronary artery disease.
    Atherosclerosis. 2025;401:118621.
    PubMed     Abstract available
    
    
    
34. TUFARO V, Torii R, Aben JP, Parasa R, et al
    Can fast wall shear stress computation predict adverse cardiac events in patients with intermediate non-flow limiting stenoses?
    Atherosclerosis. 2025;401:119099.
    PubMed     Abstract available
    
    
    
35. YI B, He L, Zhang D, Zeng M, et al
    Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes.
    Atherosclerosis. 2025;401:119092.
    PubMed     Abstract available
    
    
    
36. RAZIPOUR A, Grodecki K, Manral N, Geers J, et al
    AI-derived automated quantification of cardiac chambers and myocardium from non-contrast CT: Prediction of major adverse cardiovascular events in asymptomatic subjects.
    Atherosclerosis. 2025;401:119098.
    PubMed     Abstract available
    
    
    
37. GIBSON K, Forrest IS, Petrazzini BO, Duffy A, et al
    Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank.
    Atherosclerosis. 2025;401:119103.
    PubMed     Abstract available
    
    
    
38. MANIKPURAGE HD, Ricard J, Houessou U, Bourgault J, et al
    Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence.
    Atherosclerosis. 2025;401:119083.
    PubMed     Abstract available
    
    
    
39. DREXEL H, Mader A, Larcher B, Festa A, et al
    Remnant cholesterol and long-term incidence of death in coronary artery disease patients.
    Atherosclerosis. 2025;401:119048.
    PubMed     Abstract available
    
    
    January 2025
40. ARAUNA D, Chandia E, Nova-Lamperti E, Radojkovic C, et al
    Platelet Content from Acute Myocardial Infarction Patients: Elevated Levels of IL-6 and IL-8 and their impact on Endothelial Nitric Oxide Production.
    Atherosclerosis. 2025;403:119119.
    PubMed     Abstract available
    
    
    December 2024
41. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Myocardial infarction in second-generation immigrants compared to native-born Swedes in the total population of Sweden.
    Atherosclerosis. 2024 Dec 26:119102. doi: 10.1016/j.atherosclerosis.2024.119102.
    PubMed     Abstract available
    
    
    
42. KYHL LK, Nordestgaard BG, Tybjaerg-Hansen A, Smith GD, et al
    VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction.
    Atherosclerosis. 2024;401:119094.
    PubMed     Abstract available
    
    
    
43. JUHASZ V, Charlier FT, Zhao TX, Tsiantoulas D, et al
    Targeting the adaptive immune continuum in atherosclerosis and post-MI injury.
    Atherosclerosis. 2024;399:118616.
    PubMed     Abstract available
    
    
    
44. KATAOKA T, Morishita T, Uzui H, Sato Y, et al
    Very short-term effects of a single dose of a proprotein convertase subtilisin/kexin 9 inhibitor before percutaneous coronary intervention: A single-arm study.
    Atherosclerosis. 2024;399:118581.
    PubMed     Abstract available
    
    
    November 2024
45. MENG Q, Zhao L, Zhao N, An Y, et al
    Progression of coronary artery calcium density and major adverse cardiovascular events.
    Atherosclerosis. 2024;398:118593.
    PubMed     Abstract available
    
    
    
46. KLUNER LV, Chan K, Antoniades C
    Using artificial intelligence to study atherosclerosis from computed tomography imaging: A state-of-the-art review of the current literature.
    Atherosclerosis. 2024;398:117580.
    PubMed     Abstract available
    
    
    
47. LEIVA O, Zhou S, How J, Lee M, et al
    Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms.
    Atherosclerosis. 2024;401:119046.
    PubMed     Abstract available
    
    
    October 2024
48. SIMONY SB, Langsted A, Mortensen MB, Nordestgaard BG, et al
    Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study.
    Atherosclerosis. 2024;399:118625.
    PubMed     Abstract available
    
    
    
49. HAGAN K, Mszar R, Cainzos-Achirica M, Blaha MJ, et al
    Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida.
    Atherosclerosis. 2024;397:118551.
    PubMed     Abstract available
    
    
    
50. KILBO EDLUND K, Andersson EM, Asker C, Barregard L, et al
    Long-term ambient air pollution and coronary atherosclerosis: Results from the Swedish SCAPIS study.
    Atherosclerosis. 2024;397:117576.
    PubMed     Abstract available
    
    
    
51. GUGLIELMO M, Penso M, Carerj ML, Giacari CM, et al
    DEep LearnIng-based QuaNtification of epicardial adipose tissue predicts MACE in patients undergoing stress CMR.
    Atherosclerosis. 2024;397:117549.
    PubMed     Abstract available
    
    
    September 2024
52. ALDUJELI A, Tsai TY, Haq A, Tatarunas V, et al
    The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction.
    Atherosclerosis. 2024;398:118597.
    PubMed     Abstract available
    
    
    
53. VALLEJO-VAZ AJ, Dharmayat KI, Nzeakor N, Carrasco CP, et al
    Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study.
    Atherosclerosis. 2024;398:118589.
    PubMed     Abstract available
    
    
    
54. QIU J, Fu Y, Tian T, Mao Y, et al
    Suppression of FOXC1 induces pyroptosis of the coronary artery through activation of JAK2.
    Atherosclerosis. 2024;396:118543.
    PubMed     Abstract available
    
    
    August 2024
55. EYRICH TM, Dalila N, Christoffersen M, Tybjaerg-Hansen A, et al
    Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.
    Atherosclerosis. 2024;397:118574.
    PubMed     Abstract available
    
    
    
56. VOLLEBERG RHJA, Mol JQ, Belkacemi A, Hermanides RS, et al
    Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.
    Atherosclerosis. 2024;397:118568.
    PubMed     Abstract available
    
    
    
57. VAISAR T, Babenko I, Horvath KV, Niisuke K, et al
    Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.
    Atherosclerosis. 2024;397:118565.
    PubMed     Abstract available
    
    
    
58. CHEN JX, Lu Q, Geng T, Wang Y, et al
    Differences in HDL-related coronary heart disease risk between individuals with and without diabetes.
    Atherosclerosis. 2024;397:118553.
    PubMed     Abstract available
    
    
    
59. TRAMUJAS L, Nogueira A, Felix N, de Barros E Silva PGM, et al
    Association of colchicine use with cardiovascular and limb events in peripheral artery disease: Insights from a retrospective cohort study.
    Atherosclerosis. 2024 Aug 9:118563. doi: 10.1016/j.atherosclerosis.2024.118563.
    PubMed     Abstract available
    
    
    
60. QI X, Zhang Y, Wang Y, Sun J, et al
    Prognostic value of serum immunoglobulin M levels in patients with acute coronary syndrome.
    Atherosclerosis. 2024;395:117552.
    PubMed     Abstract available
    
    
    
61. WENTZEL JJ, Bos D, White SJ, van der Heiden K, et al
    Sex-related differences in coronary and carotid vessel geometry, plaque composition and shear stress obtained from imaging.
    Atherosclerosis. 2024;395:117616.
    PubMed     Abstract available
    
    
    
62. PATEL NH, Dave EK, Fatade YA, De Cecco CN, et al
    Epicardial adipose tissue attenuation on computed tomography in women with coronary microvascular dysfunction: A pilot, hypothesis generating study.
    Atherosclerosis. 2024;395:118520.
    PubMed     Abstract available
    
    
    
63. MIRANDA MARAVI JS, Leszczynski EC, Schwartz CS, Dev PK, et al
    Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study.
    Atherosclerosis. 2024;395:117587.
    PubMed     Abstract available
    
    
    
64. ZHANG J, Zhong Q, Lin Y, Zhang Y, et al
    Longitudinal albuminuria patterns predict coronary artery calcification progression: Findings from the Coronary Artery Risk Development in Young Adults study.
    Atherosclerosis. 2024;395:117574.
    PubMed     Abstract available
    
    
    
65. FERRARO B
    The SR-B1DeltaCT/LDLR KO mouse: A new tool to shed light on coronary artery disease.
    Atherosclerosis. 2024;395:117564.
    PubMed    
    
    
    
66. HOSHINO M, Jukema RA, Pijls N, Hoek R, et al
    Microvascular resistance reserve before and after PCI: A serial FFR and [(15)O] H(2)O PET study.
    Atherosclerosis. 2024;395:117555.
    PubMed     Abstract available
    
    
    
67. PARK CH, Kim HW, Park JT, Chang TI, et al
    Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study.
    Atherosclerosis. 2024;395:117563.
    PubMed     Abstract available
    
    
    
68. MULLIS DM, Padilla-Lopez A, Wang H, Zhu Y, et al
    Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1DeltaCT/LDLR KO mouse.
    Atherosclerosis. 2024;395:117518.
    PubMed     Abstract available
    
    
    
69. OLIVEIRA-SANTOS M, Borges-Rosa J, Silva R, Paixao L, et al
    Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT.
    Atherosclerosis. 2024;395:117481.
    PubMed     Abstract available
    
    
    July 2024
70. HUANG H, Liu J, Li Q, Qiao L, et al
    Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation.
    Atherosclerosis. 2024;394:117306.
    PubMed     Abstract available
    
    
    June 2024
71. BEN-SHABAT N, Krasun A, Fisher L, Patt YS, et al
    Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: Results from a large population-based study.
    Atherosclerosis. 2024;396:117626.
    PubMed     Abstract available
    
    
    
72. IBRAHIM S, Hartgers ML, Reeskamp LF, Zuurbier L, et al
    LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.
    Atherosclerosis. 2024 Jun 10:117610. doi: 10.1016/j.atherosclerosis.2024.117610.
    PubMed     Abstract available
    
    
    
73. GAGNON E, Bourgault J, Gobeil E, Theriault S, et al
    Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
    Atherosclerosis. 2024;393:117558.
    PubMed     Abstract available
    
    
    
74. GOUDA P, Islam S, Dover DC, Kaul P, et al
    Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome.
    Atherosclerosis. 2024;393:117477.
    PubMed     Abstract available
    
    
    
75. MASROURI S, Tamehri Zadeh SS, Shapiro MD, Khalili D, et al
    Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults.
    Atherosclerosis. 2024;393:117520.
    PubMed     Abstract available
    
    
    
76. WELSH RC, Gouda P, Dover D, Bainey KR, et al
    Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease.
    Atherosclerosis. 2024;393:117486.
    PubMed     Abstract available
    
    
    May 2024
77. PINXTERHUIS TH, Ploumen EH, van Vliet D, Gert van Houwelingen K, et al
    Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
    Atherosclerosis. 2024;392:117488.
    PubMed     Abstract available
    
    
    
78. JAIN V, Rifai MA, Kanaya AM, Shah NS, et al
    Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies.
    Atherosclerosis. 2024;392:117522.
    PubMed     Abstract available
    
    
    
79. SUGANE H, Asaumi Y, Ogata S, Kimura M, et al
    Evaluation of fractional flow reserve and atherosclerotic plaque characteristics on coronary non-contrast T1-weighted magnetic resonance imaging.
    Atherosclerosis. 2024;392:117530.
    PubMed     Abstract available
    
    
    
80. BERLOT AA, Fu X, Shea MK, Tracy R, et al
    Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2024;392:117505.
    PubMed     Abstract available
    
    
    
81. LARSSON J, Auscher S, Pararajasingam G, Heinsen LJ, et al
    Reply to: "Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition".
    Atherosclerosis. 2024;392:117524.
    PubMed    
    
    
    
82. RAZAVI AC, Raggi P, Whelton SP
    Coronary artery calcium: The canary in the coal mine.
    Atherosclerosis. 2024;392:117499.
    PubMed    
    
    
    
83. BUGIARDINI R, Gulati M
    Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity.
    Atherosclerosis. 2024;392:117500.
    PubMed     Abstract available
    
    
    
84. BERISHA-MUHARREMI V, Majnaric-Trtica L, Mujaj B
    Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition.
    Atherosclerosis. 2024;392:117484.
    PubMed    
    
    
    April 2024
85. ENGEBRETSEN I, Bugge C, Stovring H, Husebye E, et al
    Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
    Atherosclerosis. 2024;393:117550.
    PubMed     Abstract available
    
    
    
86. XIAO J, Wei H, Gao Z, Chen L, et al
    Differential age-specific associations of LDL cholesterol and body mass index with coronary heart disease.
    Atherosclerosis. 2024;393:117542.
    PubMed     Abstract available
    
    
    
87. GAGNON E, Arsenault BJ
    Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention.
    Atherosclerosis. 2024;391:117501.
    PubMed     Abstract available
    
    
    
88. HAN Y, Ren L, Fei X, Wang J, et al
    Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH).
    Atherosclerosis. 2024;391:117471.
    PubMed     Abstract available
    
    
    
89. RINALDI R, Colucci M, Torre I, Ausiello D, et al
    Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score.
    Atherosclerosis. 2024;391:117503.
    PubMed     Abstract available
    
    
    March 2024
90. MELNES T, Bogsrud MP, Christensen JJ, Rundblad A, et al
    Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease.
    Atherosclerosis. 2024;392:117507.
    PubMed     Abstract available
    
    
    
91. ESCATE R, Padro T, Perez de Isla L, Fuentes F, et al
    Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
    Atherosclerosis. 2024;392:117502.
    PubMed     Abstract available
    
    
    
92. REXHAJ E, Bar S, Soria R, Ueki Y, et al
    Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
    Atherosclerosis. 2024;392:117504.
    PubMed     Abstract available
    
    
    
93. HAKAMAA E, Goebeler S, Martiskainen M, Louhelainen AM, et al
    Sex differences in coronary atherosclerosis during the pre- and postmenopausal period: The Tampere Sudden Death Study.
    Atherosclerosis. 2024;390:117459.
    PubMed     Abstract available
    
    
    
94. GRINBERG T, Eisen A, Talmor-Barkan Y, Kornowski R, et al
    Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort.
    Atherosclerosis. 2024;390:117469.
    PubMed     Abstract available
    
    
    
95. SCHLEGEL A
    Diagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy.
    Atherosclerosis. 2024;390:117460.
    PubMed    
    
    
    
96. CHEDID G, Malik A, Daher R, Welty FK, et al
    Reply to: "Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease"".
    Atherosclerosis. 2024;390:117452.
    PubMed    
    
    
    
97. KHAN SU, Al-Mallah MH
    Air pollution and acute coronary syndrome: The air we breathe.
    Atherosclerosis. 2024;390:117453.
    PubMed    
    
    
    
98. GU SZ, Ahmed ME, Huang Y, Hakim D, et al
    Comprehensive biomechanical and anatomical atherosclerotic plaque metrics predict major adverse cardiovascular events: A new tool for clinical decision making.
    Atherosclerosis. 2024;390:117449.
    PubMed     Abstract available
    
    
    
99. CENKO E, Manfrini O, Bugiardini R
    Net adverse clinical events with P2Y(12) inhibitor therapy in older patients after percutaneous coronary interventions.
    Atherosclerosis. 2024;390:117434.
    PubMed    
    
    
    
100. ASMARIAN N, Raeisi Shahraki H
     Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease".
     Atherosclerosis. 2024;390:117426.
     PubMed    
     
     
     
101. RINALDI R, Russo M, Bonanni A, Camilli M, et al
     Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study.
     Atherosclerosis. 2024;390:117393.
     PubMed     Abstract available
     
     
     February 2024
102. OBISESAN OH, Boakye E, Wang FM, Dardari Z, et al
     Coronary artery calcium as a marker of healthy and unhealthy aging in adults aged 75 and older: The Atherosclerosis Risk in Communities (ARIC) study.
     Atherosclerosis. 2024 Feb 13:117475. doi: 10.1016/j.atherosclerosis.2024.117475.
     PubMed     Abstract available
     
     
     December 2023
103. FISHBEIN I, Inamdar VV, Alferiev IS, Bratinov G, et al
     Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.
     Atherosclerosis. 2023;390:117432.
     PubMed     Abstract available
     
     
     
104. ZHANG D, Li P, Qiu M, Liang Z, et al
     Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
     Atherosclerosis. 2023 Dec 13:117395. doi: 10.1016/j.atherosclerosis.2023.117395.
     PubMed     Abstract available
     
     
     September 2023
105. JONAS M, Genereux P, Maehara A, Ben-Yehuda O, et al
     Control of diabetes mellitus and the risk of neointimal hyperplasia after percutaneous coronary intervention: Post-hoc analysis from the BLADE-PCI trial.
     Atherosclerosis. 2023 Sep 3:117264. doi: 10.1016/j.atherosclerosis.2023.117264.
     PubMed     Abstract available
     
     
     August 2023
106. TIAN P, Liu Y, Wang J, Xing L, et al
     Correlation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes.
     Atherosclerosis. 2023 Aug 18:117242. doi: 10.1016/j.atherosclerosis.2023.117242.
     PubMed     Abstract available
     
     
     July 2023
107. BARFOROSHI S, Manubolu VS, Wang R, McClelland RL, et al
     Incremental value of ABI and CAC beyond traditional risk markers in long-term prediction of cardiovascular disease incidence in participants with diabetes and impaired fasting glucose: Multi-Ethnic Study of Atherosclerosis.
     Atherosclerosis. 2023 Jul 6:117186. doi: 10.1016/j.atherosclerosis.2023.117186.
     PubMed     Abstract available
     
     
     June 2023
108. NIELSEN S, Nyvad J, Christensen KL, Poulsen PL, et al
     Obstructive sleep apnea, coronary calcification and arterial stiffness in patients with diabetic kidney disease.
     Atherosclerosis. 2023 Jun 29:117170. doi: 10.1016/j.atherosclerosis.2023.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.